Cargando…
The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study
BACKGROUND AND METHODS: Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. Nevertheless, the isolation of these cells remains very challenging because they rarely circulate in the blood. Another current problem is the cancer-specific characterization of these cell...
Autores principales: | Theil, Gerit, Fischer, Kersten, Weber, Ekkehard, Medek, Rita, Hoda, Raschid, Lücke, Klaus, Fornara, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968821/ https://www.ncbi.nlm.nih.gov/pubmed/27479125 http://dx.doi.org/10.1371/journal.pone.0158354 |
Ejemplares similares
-
In vivo isolation of circulating tumor cells in patients with different stages of prostate cancer
por: Theil, Gerit, et al.
Publicado: (2021) -
The Adipocyte-Derived Hormone Leptin Has Proliferative Actions on Androgen-Resistant Prostate Cancer Cells Linking Obesity to Advanced Stages of Prostate Cancer
por: Hoda, M. Raschid, et al.
Publicado: (2012) -
Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study
por: He, Yutong, et al.
Publicado: (2017) -
Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single‐center study
por: Dizdar, Levent, et al.
Publicado: (2019) -
Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients
por: Theil, Gerit, et al.
Publicado: (2020)